Single case report: Paranoia reaction during treatment with interferon;Syndrome de persecution sous interferon: A propos d'un cas

Annales Medico-Psychologiques

Volumn 154, Issue 4, 1996, Pages 246-249

  Lemonnier, E ^a   Condat, B ^a   Paillere Martinot M L ^a   Chollet, R ^a   Allilaire, J F ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

depression; interferon; psychotic reaction

Indexed keywords

ANXIOLYTIC AGENT; CYAMEMAZINE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUOXETINE; GLIBENCLAMIDE; HALOPERIDOL; INTERFERON; LISINOPRIL; MAPROTILINE; METFORMIN; RECOMBINANT ALPHA2B INTERFERON; SEROTONIN AGONIST; ANTIVIRUS AGENT;

ADULT; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; DEPRESSION; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; PARANOIA; PSYCHOSIS; VIRUS HEPATITIS; ARTICLE; CHRONIC DISEASE; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ANTIVIRAL AGENTS; CHRONIC DISEASE; DEPRESSIVE DISORDER; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; INTERFERONS; MIDDLE AGED; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 0030035590     PISSN: 00034487     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Adams F., Quesada J.R., Gutterman J.U.: Neuropsychiatric Manifestations of Human Leukocyte Interferon Therapy in Patients With Cander. JAMA, 1984, 252, 7, 938-941
2. Brook M.G., McDonald J.A., Karayiannis P., Caruso L., Forster G. et al.: Randomised controlled trial of Interferon alpha 2a (RBE) (Roferon-a) for the treatment of chronic hepatitis B virus (HBV) infection factors that influence response. Journal Gut., 1989, 30, 1116-1122.
3. Creagan E.T., Ahmann D.L., Green S.J., Long H.J., Rubin J. et al.: Phase II study of recombinant leucocyte A interferon (Rifn-alpha A) in disseminated malignant melanoma. Journal Cancer., 1984, 54, 12, 2844-2849.
4. Ernstoff M.S., David C.A., Ferraresi R.W., Rudnick S., Kirkwood J.M.: Toxicity and antitumor effects of daily recombinant human interferon alpha 2. Journal Clin. Res., 1983, 30, 3, 694A.
5. Hoofgnagle J.H.: Alpha-interferon therapy of chronic hepatitis B. Current status and recommendations. Journal J. Hepato., 1990, 11 suppl. 1, s100-s107.
6. Janssen H.L., Berk L., Schalm S.W., Heijtink P.A., Hess G. et al.: Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B. Journal Gut., 1992, 33, 1094-1098.
7. Levensoa J.L. and Fallon H.J.: Fluoxétine treatment of depression caused by interferon-alpha. Amer. J. Gastroenterol, 1993, 88, 760-761.
8. McDonald E.M., Mann A.H., Thomas H.C.: Interferons as mediators of psychiatric morbidity, An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers. The Lancet, 1987, 21, 1175-1178.
9. Prasap S., Waters B., Hill P.B., Portera F.A., Riely C.A. et al.: Psychiatric side effects of interferon alpha-2 b in patients treated for hepatitis C. Clinical Research, 1992, 40, 840A.
10. Renault P.F., Hoffnagle J.F., Park Y., Mullen K.D., Peters M. et al.: Psychiatric complications of long-terme interferon alpha therapy. Arch. Intern. Med., 1987, 147, 1577-1580.
11. Wandl U.B., Kloke O., Nagel-Hiemke M., Moritz T., Becher R. et al.: Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with ph-positive chronic myelogenous leukaemia. Br. J. Haematol., 81, 4, 516-519.